Pfm Health Sciences, LP Aptinyx Inc. Transaction History

Pfm Health Sciences, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.95 - $4.38 $5.3 Million - $7.86 Million	-1,795,149 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$3.99 - $19.33 $227,362 - $1.1 Million	-56,983 Reduced 3.08%	1,795,149 $7.27 Million
Q4 2018 Feb 14, 2019	BUY	$16.15 - $28.93 $1.57 Million - $2.82 Million	97,453 Added 5.55%	1,852,132 $30.6 Million
Q3 2018 Nov 13, 2018	BUY	$20.21 - $31.85 $7.57 Million - $11.9 Million	374,763 Added 27.16%	1,754,679 $49.5 Million
Q2 2018 Aug 14, 2018	BUY	$19.83 - $24.17 $27.4 Million - $33.4 Million	1,379,916 New	1,379,916 $32.1 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.